Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.6825
-0.0124 (-1.78%)
At close: May 12, 2025, 4:00 PM
0.6900
+0.0075 (1.10%)
After-hours: May 12, 2025, 7:35 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $6.06 million as of May 12, 2025. Its market cap has decreased by -28.31% in one year.
Market Cap
6.06M
Enterprise Value
5.07M
1-Year Change
-28.31%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $6.06M, a decrease of -82.83%. That is a compound annual growth rate of -39.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 6.17M | -26.99% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |